C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/28 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2740806
The present application relates to anti-PD-L1 antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dys-functional disorders, including infection (e.g., acute and chronic) and tumor immunity.
La présente invention concerne des anticorps anti-PD-L1, un acide nucléique les codant, leurs compositions thérapeutiques et leur utilisation pour améliorer la fonction des lymphocytes T en vue de réguler positivement les réponses immunitaires à médiation cellulaire et pour le traitement de troubles dysfonctionnels des lymphocytes T, y compris une infection (par ex. aiguë et chronique) et l'immunité tumorale.
Cheung Jeanne
Chiu Henry
Irving Bryan
Lehar Sophie M.
Maecker Heather
Genentech Inc.
Smart & Biggar
LandOfFree
Anti-pd-l1 antibodies and their use to enhance t-cell function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-pd-l1 antibodies and their use to enhance t-cell function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-pd-l1 antibodies and their use to enhance t-cell function will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1591999